1. Active tuberculosis in psoriasis patients treated with TNF antagonists: a French nationwide retrospective study. (3rd June 2016) Authors: Guinard, E.; Bulai Livideanu, C.; Barthélémy, H.; Viguier, M.; Reguiai, Z.; Richard, M.A.; Jullien, D.; Beneton, N.; Bara, C.; Vabres, P.; Grandvuillemin, A.; Marguery, M.C.; Amelot, F.; Konstantinou, M.P.; Bagheri, H.; Paul, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 30:Number 8(2016:Aug.) Page Start: 1336 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Characteristics of patients with psoriasis with Psoriasis Area and Severity Index < 10 treated with biological agents: results from the French PsoBioTeq cohort. (1st November 2021) Authors: Beylot‐Barry, M.; Seneschal, J.; Tran, D.; Bachelez, H.; Beneton, N.; Dupuy, A.; Joly, P.; Jullien, D.; Mahé, E.; Paul, C.; Richard, M.‐A.; Sbidian, E.; Viguier, M.; Chosidow, O.; Tubach, F. Journal: British journal of dermatology Issue: Volume 185:Number 5(2021) Page Start: 1052 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Characteristics of patients with psoriasis with Psoriasis Area and Severity Index < 10 treated with biological agents: results from the French PsoBioTeq cohort. (31st August 2021) Authors: Beylot‐Barry, M.; Seneschal, J.; Tran, D.; Bachelez, H.; Beneton, N.; Dupuy, A.; Joly, P.; Jullien, D.; Mahé, E.; Paul, C.; Richard, M.‐A.; Sbidian, E.; Viguier, M.; Chosidow, O.; Tubach, F. Journal: British journal of dermatology Issue: Volume 185:Number 5(2021) Page Start: 1052 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical, biological and histological characteristics of bullous pemphigoid associated with anti‐PD‐1/PD‐L1 therapy: A national retrospective study. (13th April 2021) Authors: Juzot, C.; Sibaud, V.; Amatore, F.; Mansard, S.; Seta, V.; Jeudy, G.; Pham‐Ledard, A.; Benzaquen, M.; Peuvrel, L.; Le Corre, Y.; Lesage, C.; Viguier, M.; Baroudjian, B.; Dréno, B.; Quéreux, G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 8(2021) Page Start: e511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Concordance of severity scores for photographic assessment of hidradenitis suppurativa. (10th November 2019) Authors: Prouteau, C.; Dinulescu, M.; Oger, E.; Pruvost‐Balland, C.; Buche, S.; Cogrel, O.; Delage, M.; Maruani, A.; Nicol, I.; Sbidian, E.; Villani, A. P.; Viguier, M.; Chastagner, M.; Grodner, C.; Kaoutar, J.; Laurent, C.; Leducq, S.; Dupuy, A.; Droitcourt, C. Journal: British journal of dermatology Issue: Volume 182:Number 2(2020) Page Start: 515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Concordance of severity scores for photographic assessment of hidradenitis suppurativa. (1st February 2020) Authors: Prouteau, C.; Dinulescu, M.; Oger, E.; Pruvost‐Balland, C.; Buche, S.; Cogrel, O.; Delage, M.; Maruani, A.; Nicol, I.; Sbidian, E.; Villani, A. P.; Viguier, M.; Chastagner, M.; Grodner, C.; Kaoutar, J.; Laurent, C.; Leducq, S.; Dupuy, A.; Droitcourt, C. Journal: British journal of dermatology Issue: Volume 182:Number 2(2020) Page Start: 515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and safety of TNF blockers and of ustekinumab in palmoplantar pustulosis and in acrodermatitis continua of Hallopeau. (30th March 2020) Authors: Husson, B.; Barbe, C.; Hegazy, S.; Seneschal, J.; Aubin, F.; Mahé, E.; Jullien, D.; Sbidian, E.; D'Incan, M.; Conrad, C.; Brenaut, E.; Girard, C.; Richard, M.A.; Bachelez, H.; Viguier, M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 10(2020) Page Start: 2330 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Factors associated with the choice of the first biologic in psoriasis: real‐life analysis from the Psobioteq cohort. (16th July 2017) Authors: Sbidian, E.; Giboin, C.; Bachelez, H.; Paul, C.; Beylot‐Barry, M.; Dupuy, A.; Viguier, M.; Lacour, J.‐P.; Schmutz, J.‐L.; Bravard, P.; Mahé, E.; Beneton, N.; Misery, L.; Delaporte, E.; Modiano, P.; Barbarot, S.; Regnier, E.; Jullien, D.; Richard, M.‐A.; Joly, P. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 12(2017) Page Start: 2046 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Feasibility and healthcare costs of superpotent topical corticosteroid therapy in bullous pemphigoid: a prospective, observational study in an academic centre in France. (1st October 2020) Authors: Clapé, A.; Muller, C.; Plée, J.; Viguier, M.; Vanhaecke, C.; Bernard, P. Journal: British journal of dermatology Issue: Volume 183:Number 4(2020) Page Start: 775 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Feasibility and healthcare costs of superpotent topical corticosteroid therapy in bullous pemphigoid: a prospective, observational study in an academic centre in France. (30th June 2020) Authors: Clapé, A.; Muller, C.; Plée, J.; Viguier, M.; Vanhaecke, C.; Bernard, P. Journal: British journal of dermatology Issue: Volume 183:Number 4(2020) Page Start: 775 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗